Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Apoptosis ; 14(12): 1451-8, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19466552

ABSTRACT

Increased levels of reactive oxygen species (ROS) by hyperglycemia can induce apoptosis of renal cells and diabetic nephropathy. The redox balance in the renal cell seems, therefore, of the utmost importance. ROS-mediated apoptosis may be further aggravated by an inadequate cytoprotective response against ROS. When there are insufficient cytoprotective and ROS scavenging molecules, ROS lead to considerable cellular damage and to a point of no return in apoptosis. Induction of cytoprotective proteins may prevent or attenuate apoptosis, renal cell injury, and finally diabetic nephropathy. Here, we discuss some mechanisms of apoptosis and several strategies that have been probed to ameliorate, or to prevent apoptosis in the diabetic kidney.


Subject(s)
Apoptosis , Diabetic Nephropathies/physiopathology , Kidney/cytology , Reactive Oxygen Species/metabolism , Animals , Diabetic Nephropathies/metabolism , Diabetic Nephropathies/prevention & control , Humans , Kidney/metabolism
2.
J Cell Mol Med ; 13(4): 712-25, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18410527

ABSTRACT

Fibroblast apoptosis plays a crucial role in normal and pathological scar formation and therefore we studied whether the putative apoptosis-inducing factor curcumin affects fibroblast apoptosis and may function as a novel therapeutic. We show that 25-microM curcumin causes fibroblast apoptosis and that this could be inhibited by co-administration of antioxidants N-acetyl-l-cysteine (NAC), biliverdin or bilirubin, suggesting that reactive oxygen species (ROS) are involved. This is supported by our observation that 25-microM curcumin caused the generation of ROS, which could be completely blocked by addition of NAC or bilirubin. Since biliverdin and bilirubin are downstream products of heme degradation by heme oxygenase (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis. Interestingly, exposure to curcumin maximally induced HO-1 protein and HO-activity at 10-15 microM, whereas, at a concentration of >20-microM curcumin HO-1-expression and HO-activity was negligible. NAC-mediated inhibition of 25-microM curcumin-induced apoptosis was demonstrated to act in part via restored HO-1-induction, since the rescuing effect of NAC could be reduced by inhibiting HO-activity. Moreover pre-induction of HO-1 using 5-microM curcumin protected fibroblasts against 25-microM curcumin-induced apoptosis. On a functional level, fibroblast-mediated collagen gel contraction, an in vitro wound contraction model, was completely prevented by 25-microM curcumin, while this could be reversed by co-incubation with NAC, an effect that was also partially HO-mediated. In conclusion, curcumin treatment in high doses (>25 microM) may provide a novel way to modulate pathological scar formation through the induction of fibroblast apoptosis, while antioxidants, HO-activity and its effector molecules act as a possible fine-tuning regulator.


Subject(s)
Apoptosis/drug effects , Cicatrix/enzymology , Curcumin/pharmacology , Fibroblasts/cytology , Fibroblasts/enzymology , Heme Oxygenase (Decyclizing)/metabolism , Wound Healing/drug effects , Acetylcysteine/pharmacology , Antioxidants/pharmacology , Bilirubin/pharmacology , Collagen/metabolism , Dermis/cytology , Dose-Response Relationship, Drug , Fibroblasts/drug effects , Gels , Glutathione/pharmacology , Humans , Reactive Oxygen Species/metabolism
3.
Arthritis Res Ther ; 7(6): R1338-47, 2005.
Article in English | MEDLINE | ID: mdl-16277687

ABSTRACT

Osteoarthritis (OA) is a common joint disease, mainly effecting the elderly population. The cause of OA seems to be an imbalance in catabolic and anabolic factors that develops with age. IL-1 is a catabolic factor known to induce cartilage damage, and transforming growth factor (TGF)-beta is an anabolic factor that can counteract many IL-1-induced effects. In old mice, we observed reduced responsiveness to TGF-beta-induced IL-1 counteraction. We investigated whether expression of TGF-beta and its signaling molecules altered with age. To mimic the TGF-beta deprived conditions in aged mice, we assessed the functional consequence of TGF-beta blocking. We isolated knee joints of mice aged 5 months or 2 years, half of which were exposed to IL-1 by intra-articular injection 24 h prior to knee joint isolation. Immunohistochemistry was performed, staining for TGF-beta1, -2 or -3, TGF-betaRI or -RII, Smad2, -3, -4, -6 and -7 and Smad-2P. The percentage of cells staining positive was determined in tibial cartilage. To mimic the lack of TGF-beta signaling in old mice, young mice were injected with IL-1 and after 2 days Ad-LAP (TGF-beta inhibitor) or a control virus were injected. Proteoglycan (PG) synthesis (35S-sulfate incorporation) and PG content of the cartilage were determined. Our experiments revealed that TGF-beta2 and -3 expression decreased with age, as did the TGF-beta receptors. Although the number of cells positive for the Smad proteins was not altered, the number of cells expressing Smad2P strongly dropped in old mice. IL-1 did not alter the expression patterns. We mimicked the lack of TGF-beta signaling in old mice by TGF-beta inhibition with LAP. This resulted in a reduced level of PG synthesis and aggravation of PG depletion. The limited response of old mice to TGF-beta induced-IL-1 counteraction is not due to a diminished level of intracellular signaling molecules or an upregulation of intracellular inhibitors, but is likely due to an intrinsic absence of sufficient TGF-beta receptor expression. Blocking TGF-beta distorted the natural repair response after IL-1 injection. In conclusion, TGF-beta appears to play an important role in repair of cartilage and a lack of TGF-beta responsiveness in old mice might be at the root of OA development.


Subject(s)
Aging , Cartilage, Articular/metabolism , Chondrogenesis/physiology , Receptors, Transforming Growth Factor beta/metabolism , Smad2 Protein/metabolism , Transforming Growth Factor beta/metabolism , Animals , Cartilage, Articular/cytology , Cell Count , Chondrocytes/cytology , Chondrocytes/metabolism , Disease Models, Animal , Hindlimb , Image Processing, Computer-Assisted , Injections, Intra-Articular , Interleukin-1/pharmacology , Joints/metabolism , Joints/pathology , Male , Mice , Mice, Inbred C57BL , Proteoglycans/biosynthesis , Signal Transduction/physiology , Transforming Growth Factor beta/antagonists & inhibitors
4.
Osteoarthritis Cartilage ; 11(11): 773-82, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14609530

ABSTRACT

OBJECTIVE: To assess if various biological responses to transforming growth factor-beta (TGF-beta) in chondrocytes are differentially regulated by Smad-6 and Smad-7. DESIGN: Adenoviral overexpression of Smad-6 or -7 mRNA in a chondrocyte cell line was determined via semi-quantitative RT-PCR and protein overexpression was studied by immunocytochemistry. Furthermore, the effect of Smad-6 and -7 overexpression on TGF-beta-induced PAI-1 and aggrecan mRNA upregulation was studied via quantitative RT-PCR. The effect of Smad-6 and -7 overexpression on TGF-beta-induced chondrocyte proliferation was studied via DNA quantification, whereas TGF-beta-induced proteoglycan (PG) synthesis was studied by 35S-sulfate incorporation. RESULTS: Adenoviral transfection of chondrocytes with Smad-6 and -7 resulted in strong upregulation of Smad-6 and -7 mRNA levels, respectively. Immunocytochemistry showed overexpression of Smad-6 and -7 proteins in both the nucleus and cytoplasm. Smad-6 overexpression significantly inhibited TGF-beta-stimulated chondrocyte proliferation, although proliferation was not completely abolished. Smad-7 overexpression, however, completely antagonized the TGF-beta effect on proliferation. Smad-6 overexpression had no effect on TGF-beta-induced PAI-1 expression, while overexpression of Smad-7 completely blocked this TGF-beta effect. Additionally, overexpression of Smad-7, but not Smad-6, totally prevented TGF-beta-induced PG synthesis on the mRNA and protein levels. CONCLUSIONS: Adenoviral transfection of chondrocytes with Smad-6 and -7 resulted in strong upregulation of Smad-6 and -7 mRNA and protein levels. Furthermore, overexpression of Smad-7 in chondrocytes totally inhibited important TGF-beta-mediated biological responses such as proliferation and PG synthesis, while overexpressed Smad-6 had no or only a partial inhibitory effect on TGF-beta activity. We conclude that in chondrocytes distinct TGF-beta activities are differentially regulated by Smad-6 and Smad-7.


Subject(s)
Chondrocytes/cytology , DNA-Binding Proteins/physiology , Extracellular Matrix Proteins , Proteoglycans/biosynthesis , Trans-Activators/physiology , Transforming Growth Factor beta/physiology , Adenoviridae/genetics , Aggrecans , Animals , Cell Division/physiology , Cells, Cultured , Chondrocytes/metabolism , DNA-Binding Proteins/genetics , Genetic Vectors , Lectins, C-Type , Mice , Plasminogen Activator Inhibitor 1/metabolism , Proteoglycans/metabolism , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Smad6 Protein , Smad7 Protein , Trans-Activators/genetics , Transfection , Transforming Growth Factor beta/antagonists & inhibitors , Up-Regulation/physiology
5.
Ann Rheum Dis ; 61(12): 1095-8, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12429542

ABSTRACT

OBJECTIVE: To investigate if a difference exists between young and old mice in the response of articular cartilage to interleukin 1 (IL1) and transforming growth factor beta (TGFbeta) alone or in combination. METHODS: The interaction of IL1 and TGFbeta was studied in cartilage of young (three months) and old mice (18 months) both in vivo and in vitro. Therefore, IL1, TGFbeta, or IL1 together with TGFbeta was injected into the knee joints of mice on days 1, 3, and 5 before harvest of the patellae on day 6. Alternatively, isolated patellae were stimulated with IL1, TGFbeta, or IL1 together with TGFbeta in culture for 48 hours. Proteoglycan (PG) synthesis and nitric oxide (NO) production were measured. RESULTS: IL1 inhibited PG synthesis and increased NO production in cartilage of both young and old mice. On the other hand, TGFbeta stimulated PG synthesis and reduced NO production in both age groups. Importantly, TGFbeta was able to counteract IL1 mediated effects on PG synthesis and NO production in young but not in old mice. CONCLUSIONS: Contrary to the findings in young mice, the cartilage of old animals does not antagonise IL1 effects via TGFbeta. This loss of responsiveness to the pivotal cytokine TGFbeta on effects of IL1 can be important in the initiation and progression of osteoarthritis (OA).


Subject(s)
Aging/metabolism , Cartilage, Articular/drug effects , Interleukin-1/pharmacology , Proteoglycans/biosynthesis , Transforming Growth Factor beta/pharmacology , Age Factors , Animals , Cartilage, Articular/metabolism , Drug Therapy, Combination , Interleukin-1/metabolism , Male , Mice , Mice, Inbred C57BL , Nitric Oxide/biosynthesis , Patella/drug effects , Patella/metabolism , Transforming Growth Factor beta/metabolism
6.
Clin Orthop Relat Res ; (391 Suppl): S244-50, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11603708

ABSTRACT

Growth factors are obvious tools to enhance cartilage repair. Understanding of reactivities in normal and arthritic cartilage and potential side effects on other compartments in the joint will help to identify possibilities and limitations. Growth factor responses have been evaluated in normal and diseased murine knees. The main cartilage anabolic factor, insulinlike growth factor-1, shows great safety, but has little contribution in diseased cartilage because of insulinlike growth factor nonresponsiveness of arthritic chondrocytes. Transforming growth factor-beta can overrule interleukin-1 catabolic effects and can enhance cartilage repair in arthritic tissue, unlike bone morphogenetic protein-2 that only is capable of enhancing chondrocyte proteoglycan synthesis in the absence of interleukin-1. Transforming growth factor-beta and bone morphogenetic protein-2 induce chondrophyte formation at the margins of the joint. Studies with scavenging transforming growth factor beta soluble receptor identified endogenous transforming growth factor-beta involvement in spontaneous cartilage repair and chondrophyte and subsequent osteophyte formation in arthritic conditions. Osteophyte induction may hamper intraarticular transforming growth factor-beta application in the joint and warrants targeted growth factor application to cartilage lesion sites only.


Subject(s)
Cartilage, Articular/injuries , Cartilage, Articular/physiology , Growth Substances/physiology , Wound Healing , Arthritis/drug therapy , Bone Morphogenetic Protein 2 , Bone Morphogenetic Proteins/physiology , Humans , Insulin-Like Growth Factor I/physiology , Interleukin-1/physiology , Nitric Oxide/physiology , Proteoglycans/biosynthesis , Transforming Growth Factor beta/physiology , Transforming Growth Factor beta/therapeutic use , Wound Healing/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...